CRS: BJMC
Position: Community Coordinator
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
